En español
NIDA

Menu

Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs

"No Smoking" sign

Nicotine dependence is common among drug and alcohol dependent patients. This multi-site trial evaluated the effectiveness of smoking-cessation treatment with transdermal nicotine patch replacement (SC) as an adjunct to treatment-as-usual for illicit substance abuse (TAU). Cigarette smokers from five methadone-maintenance clinics and two drug and alcohol dependence treatment programs were randomly assigned to receive either SC as an adjunct to usual care or TAU. SC consisted of 1 week of group counseling before the target quit date and 8 weeks of group counseling plus transdermal nicotine patch replacement treatment after the target quit date.

CTN Protocol ID: 
CTN-0009
DSMB ID: 
NIDA-CTN-0009
Enrollment Status: 
Completed
ClinicalTrials.gov ID: 
Primary Outcomes Article: 

Reid, M., et al. (2008).  Smoking cessation treatment in community-based substance abuse rehabilitation programs.  Journal of Substance Abuse Treatment 35(1):68-77.
http://www.ncbi.nlm.nih.gov/pubmed/17951021

Principal Investigator(s)
John Rotrosen, M.D.
Professor
NYU School of Medicine
Department of Psychiatry
423 East 23rd Street, 17W
New York, NY 10010
john.rotrosen@nyumc.org

Available Brochures

    Featured Publication

    Featured Publication

    Drugs, Brains, and Behavior - The Science of Addiction

    As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.